Amount Raised
$150 Million
Round Type
Post-IPO Equity
IrvineBiotechnologyHealthcareInvestors
Description
On September 15, 2026, Beta Bionics, Inc. entered into an underwriting agreement for a public offering of common stock. The company expects to raise approximately $150 million from the sale of 7,652,175 shares at a price of $17.25 each. Additionally, warrants to purchase shares are included for certain investors
Quick answer
Beta Bionics raised $150 Million in a Post-IPO Equity round, dated September 17, 2026. Investors: Wells Fargo Securities, LLC, Leerink Partners LLC, J.P. Morgan Securities LLC and Piper Sandler & Co. Beta Bionics is based in Irvine, California, United States.
- How much did Beta Bionics raise?
- Beta Bionics raised $150 Million in a Post-IPO Equity round on September 17, 2026.
- Who invested in Beta Bionics?
- Wells Fargo Securities, LLC, Leerink Partners LLC, J.P. Morgan Securities LLC and Piper Sandler & Co. are named as investors in this round.
- What does Beta Bionics do?
- Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with..
- Where is Beta Bionics based and how big is it?
- Beta Bionics is based in Irvine, California, United States. Fundz records about 455 employees.
- Who are the decision-makers at Beta Bionics?
- Fundz holds 2 contacts at Beta Bionics, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Beta Bionics that raised within 45 days of this round, from Fundz verified event records.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
- Araceli Biosciences raised $4.5M (Seed) on October 20, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- X4 Pharmaceuticals raised $150M (Debt Financing) on October 12, 2026.
- CollPlant Biotechnologies Ltd raised $3.7M (Post-IPO Equity) on October 9, 2026.
Who to call at Beta Bionics, and when
A new round usually means Beta Bionics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Beta Bionics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Beta Bionics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Beta Bionics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beta Bionics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Beta Bionics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.